Posted in | News | Microbotics

GeRM Security System Engineered into Pilus Energy's BactoBots

Tauriga Sciences, Inc. or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today highlighted the Genetic Rights Management ("GeRM") synthetic biology security system developed for Pilus Energy LLC ("Pilus Energy") to protect its proprietary BactoBots™ technology platform.

The anti-theft and protection against environmental release GeRM system is engineered into Pilus Energy's genetically enhanced products, specifically its synthetic biology based bacterial robot ("BactoBots™"). GeRM "keys" are hidden in a consumable powder. That powder is occasionally added to the wastewater in the BactoBots operating environment. If the dissolved GeRM keys are separated from the BactoBots, then the BactoBots self-destruct; beginning with the corruption of their deoxyribonucleic acid ("DNA") and/or ribonucleic acid ("RNA").

As a result, Pilus Energy is able to rapidly license its technology platform and expertise in synthetic biology engineering to any reputable firm in the world. A Licensee is enabled to manufacture ("Manufacturer") the BactoBots™ and provide the commercial product to an in-market licensed Distributor ("Distributor"). Pilus Energy then sends the consumable GeRM key powder to the Distributor, who packages it with the BactoBots™ for the Distributor's marketplace.

In this way, Pilus Energy facilitates a global synthetic biology market with an integrated system of anti-theft and another level of protection against environmental release. Because GeRM enables licensing and consumable sales, Pilus Energy does not require the facilities, personnel, and regulatory overhead that come with centralized production and distribution of products.

In short, GeRM keys enable local control and economic development with lower overhead and risk. By licensing the knowledge of manufacturing BactoBots™, Pilus Energy creates a force-multiplier effect.

The GeRM Keys' system of protection is protected by the following Intellectual Property ("IP"): USA Provisional Patent Filing, 61/790-735, March 15, 2013.


Tauriga's CEO Seth M. Shaw, expressed, "The Company continues to present to a number of institutional investors and questions have arisen as to Pilus Energy's ability to protect its proprietary technology from theft, cloning, and reverse engineering. The scientists at Pilus Energy have established an outstanding system of protection through the GeRM Keys and as a result, the technology can be efficiently exported to the global marketplace without risk of counterfeiting or theft. Tauriga's management has worked extremely hard to complete the acquisition of Pilus Energy and anticipates that the closing of such acquisition will be announced within days."

Bacterial Robotics, CEO, Jason E. Barkeloo, finished, "Our GeRM synthetic biology security system enables a business model that disincentives reverse-engineering and theft. Apple Computer's iTunes® model made theft of digital assets using Napster irrelevant. With iTunes® it was cheaper and less risky to pay ninety-nine cents for a song, load it to your iPod®, and go, than it was to hack the digital rights management, or DRM, and steal the song. Similarly, GeRM makes it easier to distribute the knowledge to manufacture and distribute BactoBots. Sure, someone can hack the GeRM. But with the economic incentive and intellectual property protections, why not just license it?"

An illustrative briefing of the GeRM-enabled security system will be available later today on the corporate website for Tauriga Sciences, Inc. at: (

On November 25, 2013, the Company signed a definitive agreement to acquire Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Upon consummation of the proposed reverse merger, which has been unanimously ratified by Tauriga's board of directors, Pilus Energy will become a wholly-owned subsidiary of Tauriga.

About Tauriga Sciences, Inc.:

Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at (

About Pilus Energy LLC

A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). For more information, please visit Pilus Energy's web site, (

About Bacterial Robotics LLC

A pioneer in the emerging synthetic biology industry, Bacterial Robotics is headquartered in Cincinnati, Ohio (USA). The Company specializes in identifying markets for developing and deploying BactoBots(TM) and ViruBots(TM); microscopic organism-based robots that produce, build, sense, and perform functions. Please visit the corporate website at for more information.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.